---
title: Congenica achieved ISO 27001 and NHS IGT accreditation
description: Congenica achieved ISO 27001 and NHS IGT accreditation
image: https://blog.congenica.com/hubfs/ISO27001-1.jpg
---

- [Our Customers and Partners](http://www.congenica.com/our-customers)
- [Our Product Portfolio](http://www.congenica.com/congenica-products) 
    - **Inherited Diseases** 
          - [Rare Disease](http://www.congenica.com/congenica-rare-disease)
          - [Inherited Cancer](http://www.congenica.com/congenica-inherited-cancer)
          - [Prenatal Health](http://www.congenica.com/congenica-prenatal)
          - [Carrier Screening](http://www.congenica.com/congenica-carrier-screening)
          - [Neurodevelopmental Disorders](http://www.congenica.com/congenica-neuro)
    - **Somatic Oncology** 
          - [Solid Tumours](http://www.congenica.com/congenica-oncology)
    - **Pathogen** 
          - [Pathogen Surveillance](http://www.congenica.com/congenica-pathogen-surveillance)
- [Our Services](http://www.congenica.com/congenica-services) 
    - [Clinical Interpretation Services](http://www.congenica.com/congenica-clinical-interpretation-services)
    - [Professional Services](http://www.congenica.com/professional-services)
    - [Customer Support](http://www.congenica.com/customer-support)
    - [Pharma Services](http://www.congenica.com/pharma-services)
- Resources 
    - [Publications](http://www.congenica.com/publications)
    - [Supporting materials](http://www.congenica.com/resources)
    - [News](https://blog.congenica.com/)
    - [Events and webinars](http://www.congenica.com/events-webinars)
- [About us](http://www.congenica.com) 
    - [Leadership Team](http://www.congenica.com/leadership)
    - [Quality](http://www.congenica.com/quality)
    - [Investors](http://www.congenica.com/investors)
    - [People and Vacancies](http://www.congenica.com/people)
- [Contact us](http://www.congenica.com/contact)

Login

##### Please select your location and reference genome:

[America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/)

[Overview](https://blog.congenica.com) [Congenica achieved ISO 27001 and NHS IGT accreditation](https://blog.congenica.com/2016/01/21/congenica-achieved-iso-27001-and-nhs-igt-accreditation)

![Congenica achieved ISO 27001 and NHS IGT accreditation](https://blog.congenica.com/hubfs/ISO27001-1.jpg)

 News

# Congenica achieved ISO 27001 and NHS IGT accreditation

 1/21/2016     |    0 min read

Congenica, a world leading developer of genome analysis technologies, places the highest importance on data security and information governance and is therefore pleased to announce that it has successfully achieved two major milestones: [ISO 27001 accreditation](https://www.british-assessment.co.uk/services/iso-certification/iso-27001-certification/#pin205723) and compliance with the [NHS Information Governance Toolkit ](https://www.igt.hscic.gov.uk/)(IGT). These external validations provide independent assurance of the strength of Congenica’s information security management system (ISMS).

ISO 27001 is a widely adopted global security standard that sets out requirements and best practices for a comprehensive approach to managing company and customer information. Systematic risk assessments, data encryption, and robust data backup procedures are used to meet the standard and maintain the security and privacy of customers’ data. This important milestone enables Congenica to provide services to public sector organisations, such as the NHS and Genomics England, in the handling of genetic and genomic data.

The NHS has developed its own set of information governance principles to ensure a consistent approach to the management of personal data. Organisations working with the NHS who process patient data within its secure N3 network are required to meet these IGT requirements. With the rapid adoption of Congenica’s Sapientia™ genomic software by NHS diagnostic laboratories, Congenica is pleased to be able to offer them the highest level of information and data security.

Nick Lench, COO comments: “The analysis and storage of genetic information is a deeply personal and sensitive subject that Congenica treats very seriously; we are committed to maintaining the highest standards of security and confidentiality to ensure the trust of all our stakeholders.”

More information on our security and compliance can be found [here](https://www.congenica.com/privacy-policy/).

**About Congenica**  
Congenica is a world leading developer of genome-based discovery and diagnostic technologies.  The Cambridge, UK-based company is a spin-out from the Wellcome Trust Sanger Institute and was founded by scientists and clinicians at the leading edge of genomic analysis.  
Congenica has developed the SapientiaTM technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. It is based on pioneering research from the Wellcome Trust Sanger Institute, NHS clinicians and regional genetic testing laboratories. This underlying technology has been validated by leading independent institutes and clinicians, including Genomics England Ltd. (www.congenica.com).

CongenicaTM and SapientiaTM are registered trademarks of Congenica Ltd.

---

<http://www.facebook.com/share.php?u=https://blog.congenica.com/2016/01/21/congenica-achieved-iso-27001-and-nhs-igt-accreditation&utm_medium=social&utm_source=facebook> <http://www.linkedin.com/shareArticle?mini=true&url=https://blog.congenica.com/2016/01/21/congenica-achieved-iso-27001-and-nhs-igt-accreditation&utm_medium=social&utm_source=linkedin> <https://twitter.com/intent/tweet?original_referer=https://blog.congenica.com/2016/01/21/congenica-achieved-iso-27001-and-nhs-igt-accreditation&utm_medium=social&utm_source=twitter&url=https://blog.congenica.com/2016/01/21/congenica-achieved-iso-27001-and-nhs-igt-accreditation&utm_medium=social&utm_source=twitter&source=tweetbutton&text=>

### Related articles

![SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine](https://blog.congenica.com/hs-fs/hubfs/New%20logos/Congenica%20%26%20SeqOne%20Logo%20Without%20Tagline%20RGB.png?width=320&height=192&name=Congenica%20%26%20SeqOne%20Logo%20Without%20Tagline%20RGB.png)

 9/2/2025

#### [SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine](https://blog.congenica.com/seqone-acquires-congenica-to-create-a-global-leader-in-ai-powered-genomic-medicine)

Strategic acquisition of UK genomics leader Congenica reinforces SeqOne market position and footprint - servicing over 160 labs in 30+ countries

![Congenica showcased in Genomics Spotlight 2024 Report](https://blog.congenica.com/hs-fs/hubfs/male%20doc%20with%20child%20and%20mum%20light%20small%20.jpg?width=320&height=192&name=male%20doc%20with%20child%20and%20mum%20light%20small%20.jpg)

 11/6/2024

#### [Congenica showcased in Genomics Spotlight 2024 Report](https://blog.congenica.com/congenica-showcased-in-recently-launched-genomics-spotlight-2024-report)

We are thrilled to announce that Congenica is one of the companies showcased in the recently launched Genomics Spotlight 2024 report produced by the UK Department for Business and Trade (DBT).

![Congenica Named Best Genomic Data Analysis Software Company 2024 by GHP](https://blog.congenica.com/hs-fs/hubfs/Onco%20.png?width=320&height=192&name=Onco%20.png)

 6/19/2024

#### [Congenica Named Best Genomic Data Analysis Software Company 2024 by GHP](https://blog.congenica.com/congenica-named-best-genomic-data-analysis-software-company-2024-by-ghp)

We are thrilled to announce that Congenica has been awarded the title of "Best Genomic Data Analysis Software Company 2024" by Global Health & Pharma Magazine. 

##### Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.

- [Privacy Policy](http://www.congenica.com/privacy-policy)
- [Cookie Policy](http://www.congenica.com/cookie-policy)

<https://twitter.com/congenica> <https://en-gb.facebook.com/congenica/> <https://www.linkedin.com/company/congenica/> 

Log in to Congenica

##### Please select your location and reference genome:

[America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/)

![CE](https://blog.congenica.com/hs-fs/hubfs/CE.png?width=80&height=80&name=CE.png) ![ISO-27001](https://blog.congenica.com/hs-fs/hubfs/ISO-27001.jpg?width=80&height=80&name=ISO-27001.jpg) ![TR-Testmark_9000030872_EN_2024_CMYK](https://blog.congenica.com/hs-fs/hubfs/2023%20website%20images/TR-Testmark_9000030872_EN_2024_CMYK.png?width=80&height=80&name=TR-Testmark_9000030872_EN_2024_CMYK.png) ![HIPAA Compliant](https://blog.congenica.com/hs-fs/hubfs/HIPAA%20Compliant.png?width=80&height=80&name=HIPAA%20Compliant.png)

Copyright © 2026 Congenica Ltd. Company number: 8273616 Registered in England and Wales.